The TGF-β cytokines are often overexpressed in tumors: TGF-β1 induces EndMT in melanoma [62] and hepatocellular carcinoma [63], and TGF-β2 in esophageal carcinoma [18] and invasive colon carcinoma [21]. Here, TGFB1 is linked to hepatocellular carcinoma.